MARLENA GIROUARD

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family COSTA MESA, CA NPI 1548857162

General Payments — all program years on this page

$4,854.35

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 145
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $675.63 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $585.6420
Education $89.991

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $290.4514
2022 $1,404.8857
2023 $2,483.3953
2024 $675.6321

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086830693 Novartis Pharmaceuticals Corporation $28.74 01/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089426317 Daiichi Sankyo Inc. $19.65 02/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104550408 AstraZeneca Pharmaceuticals LP $24.81 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104566816 AstraZeneca Pharmaceuticals LP $23.33 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104701593 AstraZeneca Pharmaceuticals LP $19.34 07/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104764070 AstraZeneca Pharmaceuticals LP $30.30 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107175728 ABBVIE INC. $20.05 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107175730 ABBVIE INC. $26.66 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107175732 ABBVIE INC. $23.15 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107175734 ABBVIE INC. $19.92 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110813798 Eisai Inc. $18.52 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110813800 Eisai Inc. $21.72 02/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110813802 Eisai Inc. $28.18 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113855551 PUMA BIOTECHNOLOGY, INC. $27.56 01/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131593379 PFIZER INC. $115.71 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133173537 Genentech USA, Inc. $20.83 01/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139168925 RECORDATI_RARE_DISEASES_INC. $23.29 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139476896 Astellas Pharma US Inc $28.98 01/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139520639 Astellas Pharma US Inc $13.49 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139547405 Astellas Pharma US Inc $89.99 11/20/2024 Education Undisputed 01/23/2026 View at CMS
1152546410 Myriad Genetic Laboratories, Inc. $51.41 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.